經導管栓塞和封堵裝置市場規模、佔有率、成長分析（按類型、應用和地區）- 2024-2031 年產業預測

Transcatheter Embolization and Occlusion Devices Market Size, Share, Growth Analysis, By Type (Coil, Non-Coil), By Application (Peripheral Vascular Disease, Oncology), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月02日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，經導管栓塞和封堵裝置的全球市場規模估值為45億美元，從2023年的48.2億美元成長到2031年的84.1億美元，並預計在預測期內成長（2024-2031年) 複合年成長率為 7.20%）。

經導管栓塞和閉合裝置的全球市場最近經歷了顯著成長，因為它們作為微創解決方案可以有效抑製或減少異常血管和組織的血流。這些重要的醫療工具對於治療腫瘤、動脈瘤和血管畸形等多種疾病至關重要。老年人更容易罹患心血管疾病和各種癌症，增加了對微創治療方法的需求。此外，醫療保健支出的快速成長以及新興經濟體醫療保健基礎設施的進步正在進一步推動市場擴張。這些趨勢標誌著向創新醫療技術的穩定轉變，這些技術提供更安全、更有效的治療方法，將經導管栓塞和閉合裝置定位為現代醫療保健的重要組成部分。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Boston Scientific Corporation（US）
Terumo Corporation（Japan）
Medtronic（Ireland）
Abbott（US）
Cook Medical Inc.（US）
Penumbra, Inc.（US）
Johnson & Johnson（US）
Guerbet SA（France）
Merit Medical Systems, Inc.（US）
AngioDynamics, Inc.（US）
B. Braun Melsungen AG（Germany）
Humares（Germany）
Inari Medical, Inc.（US）
MicroVention, Inc.（US）
Endospan Ltd.（Israel）
Teleflex Incorporated（US）
Kaneka Corporation（Japan）
SentreHEART, Inc.（US）
Vascular Technologies（US）

簡介目錄

Product Code: SQMIG35A2295

Global Transcatheter Embolization and Occlusion Devices Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 4.82 billion in 2023 to USD 8.41 billion by 2031, growing at a CAGR of 7.20% during the forecast period (2024-2031).

The global market for transcatheter embolization and occlusion devices has witnessed remarkable growth recently, driven by their effectiveness as minimally invasive solutions for obstructing or diminishing blood flow to abnormal vessels or tissues. These essential medical tools are pivotal in treating a range of conditions such as tumors, aneurysms, and vascular malformations. A notable factor propelling market demand is the escalating geriatric population, as older adults are more susceptible to cardiovascular diseases and various cancers, thereby increasing the necessity for minimally invasive treatment modalities. Additionally, the surge in healthcare expenditure, coupled with advancements in healthcare infrastructure across emerging economies, is further bolstering market expansion. These trends indicate a steady shift toward innovative medical technologies that offer safer and more efficient treatment options, positioning transcatheter embolization and occlusion devices as a critical component in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Embolization and Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Embolization and Occlusion Devices Market Segmental Analysis

Global Transcatheter Embolization and Occlusion Devices Market is segmented by Type, Application, and region. Based on Type, the market is segmented into Coil, and Non-Coil. Based on Application, the market is segmented into Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Transcatheter Embolization and Occlusion Devices Market

The Global Transcatheter Embolization and Occlusion Devices market is significantly driven by the growing demand for minimally invasive treatment options. As healthcare continues to prioritize patient-centric care, both patients and medical professionals favor procedures that facilitate quicker recovery, shorter hospital stays, and a lowered likelihood of complications compared to traditional surgical approaches. This shift in preference not only reflects advancements in medical technology but also highlights the essential role of transcatheter embolization and occlusion devices in various therapeutic applications, thereby propelling market growth. Consequently, these devices are becoming integral to modern interventional radiology and vascular surgery practices.

Restraints in the Global Transcatheter Embolization and Occlusion Devices Market

The Global Transcatheter Embolization and Occlusion Devices market faces significant restraint due to the potential complications and adverse events associated with these procedures. Despite their efficacy, risks such as device migration, vessel perforation, thrombosis, or allergic reactions to embolic agents may deter both healthcare providers and patients from opting for such interventions. These concerns not only decrease patient confidence but also compel clinicians to reconsider the choice of these devices over alternative treatment options, ultimately hindering market growth. Increased scrutiny and regulatory hurdles, fueled by these risks, may further challenge the adoption and advancement of transcatheter technologies.

Market Trends of the Global Transcatheter Embolization and Occlusion Devices Market

The Global Transcatheter Embolization and Occlusion Devices market is witnessing significant growth, driven by the adoption of advanced technologies that enhance safety and efficacy. As the prevalence of chronic diseases rises, there is an increasing demand for minimally invasive procedures, further propelling market expansion. Additionally, favorable reimbursement policies are promoting greater utilization of these devices. Innovation is at the forefront, with emerging technologies continually improving treatment options and outcomes for various medical conditions. This confluence of factors positions the market for robust growth, as healthcare providers and patients increasingly recognize the benefits of transcatheter solutions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Patent Analysis
Regulatory Landscape
Top Investment Analysis
Key Success Factor
Degree of Competition

Transcatheter Embolization and Occlusion Devices Market byType

Market Overview
Coil
- Pushable Coils
- Detachable Coils
Non-Coil
- Flow Diverting Devices
- Embolization Particles
- Liquid Embolics
- Others

Transcatheter Embolization and Occlusion Devices Market byApplication

Market Overview
Peripheral Vascular Disease
- Arterial Blockage
- Venous Blood clot
- Others
Oncology
Neurology
- Brain Aneurysm
- Cerebral Arteriovenous Malformations
- Others
Urology
- Benign Prostatic Hyperplasia/Urinary Retention
- Others
- Varicocele
Others

Transcatheter Embolization and Occlusion Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Humares (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inari Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endospan Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SentreHEART, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments